HomePOAI • NASDAQ
Predictive Oncology Inc
add
$0.96
0.00%
Pre-market:(0.91%)-0.0087
$0.95
Closed: Jun 5, 8:21:13 AM UTC-4 · USD · NASDAQ · Disclaimer
Market news
Financials
Income Statement
Revenue
Net Income
Revenue
Net income
(USD) | Mar 2025info | Y/Y change |
---|---|---|
Revenue | 110.31K | -73.71% |
Operating expense | 2.35M | -47.37% |
Net income | -2.44M | 42.10% |
Net profit margin | -2.21K | -120.28% |
Earnings per share | — | — |
EBITDA | -2.25M | 44.67% |
Effective tax rate | — | — |
Balance Sheet
Total Assets
Total Liabilities
Total assets
Total liabilities
(USD) | Mar 2025info | Y/Y change |
---|---|---|
Cash and short-term investments | 3.09M | -40.59% |
Total assets | 5.87M | -44.65% |
Total liabilities | 6.01M | -8.15% |
Total equity | -145.80K | — |
Shares outstanding | 8.93M | — |
Price to book | -47.88 | — |
Return on assets | -105.48% | — |
Return on capital | -308.99% | — |
Cash Flow
Net Change in Cash
Net change in cash
(USD) | Mar 2025info | Y/Y change |
---|---|---|
Net income | -2.44M | 42.10% |
Cash from operations | -756.35K | 77.86% |
Cash from investing | 625.00K | 20,713.46% |
Cash from financing | 2.50M | 2,324.47% |
Net change in cash | 2.37M | 167.06% |
Free cash flow | 904.57K | 148.98% |
Previous close
$0.96
Year range
$0.55 - $3.06
Market cap
8.55M USD
Avg Volume
186.90K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
About
Founded
2002
Headquarters
Website
Employees
24